Magle Chemoswed Holding AB (publ) (STO:MAGLE)
Sweden · Delayed Price · Currency is SEK 0.8650
-0.8150 (-48.51%)
Sep 24, 2026, 5:23 PM CET
STO:MAGLE Market Cap
STO:MAGLE has a market cap or net worth of 26.18 million as of September 24, 2026. Its market cap has decreased by -93.33% in one year.
Market Cap
26.18M
Enterprise Value
368.08M
Revenue
275.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.87
ChartMarket Cap Chart
Since June 30, 2020, STO:MAGLE's market cap has decreased from 205.10M to 26.18M, a decrease of -87.24%. That is a compound annual growth rate of -28.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 26.18M | -92.80% |
| Dec 30, 2025 | 363.43M | -43.25% |
| Dec 30, 2024 | 640.39M | 135.30% |
| Dec 29, 2023 | 272.16M | -5.97% |
| Dec 30, 2022 | 289.44M | -10.37% |
| Dec 30, 2021 | 322.92M | -29.72% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Spago Nanomedical AB | 77.28M |
| Annexin Pharmaceuticals AB | 71.30M |
| AcouSort AB | 65.82M |
| Modus Therapeutics Holding AB | 58.74M |
| OncoZenge AB | 47.69M |
| Fluicell AB | 42.58M |
| ExpreS2ion Biotech Holding AB | 29.21M |
| Alligator Bioscience AB | 13.19M |